By Bart Schaneman

Alaska’s recreational marijuana business owners are fighting for the right to outfit their shops with a separate space to accommodate full consumption, including smoking, on their premises.

The move is largely designed so they can offer the 1 million-plus tourists who visit the state every year a place to consume cannabis.

Bart Schaneman  |
July 20, 2017

By Omar Sacirbey

Massachusetts’ recreational marijuana market can expect an influx of business license applications now that lawmakers have agreed on an adult-use bill that will serve as the framework for the new industry.

The market will be strong, observers predict, but the stakes will be high for a coveted license.

Omar Sacirbey  |
July 19, 2017

A Canadian marijuana growth strategy: Q&A with Canopy CEO Bruce Linton

Omar Sacirbey  | July 18, 2017

By Omar Sacirbey

Canada’s biggest medical marijuana producer, Canopy Growth in Smith Falls, Ontario, serves more than one third of the nation's MMJ patients and generated 203 million Canadian dollars ($160 million) in revenue last year.

But the company also lost CA$16.7 million.

How? An aggressive expansion plan.

Omar Sacirbey  |
July 18, 2017

By Omar Sacirbey and John Schroyer

Nevada works to avert a recreational marijuana supply shortage, New Hampshire adds chronic pain and PTSD to its medical cannabis qualifying conditions, and Maryland reorganizes its MMJ commission.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Omar Sacirbey  |
July 14, 2017

Cannabis valuations: Finding the right sales price for a marijuana business

John Schroyer  | July 13, 2017

By John Schroyer

Say you’ve had a marijuana business for a few years.

And you’re tired of running it and want to cash out, or maybe you’ve encountered an excited potential buyer looking to get into the industry.

The immediate question is: How much is the company worth?

John Schroyer  |
July 13, 2017

Canadian cannabis M&As ready to ‘go crazy’: Q&A with Aurora CFO Glen Ibbott

Omar Sacirbey  | July 12, 2017

By Omar Sacirbey

Glen Ibbott had a successful career as a top executive with U.S. life sciences companies worth hundreds of millions of dollars that listed on the Nasdaq Stock Market.

But it wasn’t hard for Canada’s Aurora Cannabis to lure Ibbott north of the border to become the medical marijuana producer’s chief financial officer.

Omar Sacirbey  |
July 12, 2017